210 related articles for article (PubMed ID: 29223477)
1. Immuno-oncology from the perspective of somatic evolution.
González S; Volkova N; Beer P; Gerstung M
Semin Cancer Biol; 2018 Oct; 52(Pt 2):75-85. PubMed ID: 29223477
[TBL] [Abstract][Full Text] [Related]
2. Immuno-oncology-101: overview of major concepts and translational perspectives.
Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
[TBL] [Abstract][Full Text] [Related]
3. Humanized Mice for the Study of Immuno-Oncology.
De La Rochere P; Guil-Luna S; Decaudin D; Azar G; Sidhu SS; Piaggio E
Trends Immunol; 2018 Sep; 39(9):748-763. PubMed ID: 30077656
[TBL] [Abstract][Full Text] [Related]
4. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer.
Chouaib S; Meslin F; Thiery J; Mami-Chouaib F
Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109
[TBL] [Abstract][Full Text] [Related]
5. Pooled in vivo screens for cancer immunotherapy target discovery.
Lane-Reticker SK; Manguso RT; Haining WN
Immunotherapy; 2018 Mar; 10(3):167-170. PubMed ID: 29370725
[No Abstract] [Full Text] [Related]
6. Epigenetics and immunotherapy: The current state of play.
Dunn J; Rao S
Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
[TBL] [Abstract][Full Text] [Related]
7. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
8. Tumour escape mechanisms and their therapeutic implications in combination tumour therapy.
Bhutia SK; Mallick SK; Maiti TK
Cell Biol Int; 2010 Apr; 34(5):553-63. PubMed ID: 20384587
[TBL] [Abstract][Full Text] [Related]
9. The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
Workenhe ST; Verschoor ML; Mossman KL
Future Oncol; 2015; 11(4):675-89. PubMed ID: 25686121
[TBL] [Abstract][Full Text] [Related]
10. Genomic Approaches to Understanding Response and Resistance to Immunotherapy.
Braun DA; Burke KP; Van Allen EM
Clin Cancer Res; 2016 Dec; 22(23):5642-5650. PubMed ID: 27698000
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy.
Adachi K; Tamada K
Cancer Sci; 2015 Aug; 106(8):945-50. PubMed ID: 25981182
[TBL] [Abstract][Full Text] [Related]
12. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
13. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
14. Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.
Sucker A; Zhao F; Pieper N; Heeke C; Maltaner R; Stadtler N; Real B; Bielefeld N; Howe S; Weide B; Gutzmer R; Utikal J; Loquai C; Gogas H; Klein-Hitpass L; Zeschnigk M; Westendorf AM; Trilling M; Horn S; Schilling B; Schadendorf D; Griewank KG; Paschen A
Nat Commun; 2017 May; 8():15440. PubMed ID: 28561041
[TBL] [Abstract][Full Text] [Related]
15. The intricate dance of tumor evolution: Exploring immune escape, tumor migration, drug resistance, and treatment strategies.
Guo X; Bian X; Li Y; Zhu X; Zhou X
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167098. PubMed ID: 38412927
[TBL] [Abstract][Full Text] [Related]
16. Principles of immunotherapy.
Olszanski AJ
J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):670-2. PubMed ID: 25995426
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy as a promoter and suppressor of malignant growth.
Vasudevan A; Schukken KM; Sausville EL; Girish V; Adebambo OA; Sheltzer JM
Nat Rev Cancer; 2021 Feb; 21(2):89-103. PubMed ID: 33432169
[TBL] [Abstract][Full Text] [Related]
18. Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research.
Overgaard NH; Fan TM; Schachtschneider KM; Principe DR; Schook LB; Jungersen G
ILAR J; 2018 Dec; 59(3):247-262. PubMed ID: 30476148
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis for response to cancer immunotherapy.
Gruber K
Lancet Oncol; 2017 Sep; 18(9):e521. PubMed ID: 28826592
[No Abstract] [Full Text] [Related]
20. Models for Immuno-oncology Research.
Cancer Cell; 2020 Aug; 38(2):145-147. PubMed ID: 32781038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]